ACTB and mesenchymal cell neoplasm: Herein, we report a GLI1-altered mesenchymal tumor with ACTB fusion and unique immunohistochemical staining for SSTR2A and will discuss how this staining can impact the differential diagnosis of GLI1-altered mesenchymal tumors.